The E Loop of the Transmitter Binding Site Is a Key Determinant of the Modulatory Effects of Physostigmine on Neuronal Nicotinic α4β2 Receptors
- 1 February 2017
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 91 (2) , 100-109
Abstract
Physostigmine is a well known inhibitor of acetylcholinesterase, which can also activate, potentiate, and inhibit acetylcholine receptors, including neuronal nicotinic receptors comprising α4 and β2 subunits. We have found that the two stoichiometric forms of this receptor differ in the effects of physostigmine. The form containing three copies of α4 and two of β2 was potentiated at low concentrations of acetylcholine chloride (ACh) and physostigmine, whereas the form containing two copies of α4 and three of β2 was inhibited. Chimeric constructs of subunits indicated that the presence of inhibition or potentiation depended on the source of the extracellular ligand binding domain of the subunit. Further sets of chimeric constructs demonstrated that a portion of the ACh binding domain, the E loop, is a key determinant. Transferring the E loop from the β2 subunit to the α4 subunit resulted in strong inhibition, whereas the reciprocal transfer reduced inhibition. To control the number and position of the incorporated chimeric subunits, we expressed chimeric constructs with subunit dimers. Surprisingly, incorporation of a subunit with an altered E loop had similar effects whether it contributed either to an intersubunit interface containing a canonical ACh binding site or to an alternative interface. The observation that the α4 E loop is involved suggests that physostigmine interacts with regions of subunits that contribute to the ACh binding site, whereas the lack of interface specificity indicates that interaction with a particular ACh binding site is not the critical factor.Keywords
This publication has 33 references indexed in Scilit:
- Additional Acetylcholine (ACh) Binding Site at α4/α4 Interface of (α4β2)2α4 Nicotinic Receptor Influences Agonist SensitivityJournal of Biological Chemistry, 2011
- Unraveling the High- and Low-Sensitivity Agonist Responses of Nicotinic Acetylcholine ReceptorsJournal of Neuroscience, 2011
- Principles of activation and permeation in an anion-selective Cys-loop receptorNature, 2011
- A Portable Site: A Binding Element for 17β-Estradiol Can Be Placed on Any Subunit of a Nicotinic α4β2 ReceptorJournal of Neuroscience, 2011
- α-Conotoxin AuIB Isomers Exhibit Distinct Inhibitory Mechanisms and Differential Sensitivity to Stoichiometry of α3β4 Nicotinic Acetylcholine ReceptorsJournal of Biological Chemistry, 2010
- The Positive Allosteric Modulator Morantel Binds at Noncanonical Subunit Interfaces of Neuronal Nicotinic Acetylcholine ReceptorsJournal of Neuroscience, 2009
- Pentameric concatenated (α4)2(β2)3 and (α4)3(β2)2 nicotinic acetylcholine receptors: subunit arrangement determines functional expressionBritish Journal of Pharmacology, 2009
- Activation and Block of the Adult Muscle-Type Nicotinic Receptor by Physostigmine: Single-Channel StudiesMolecular Pharmacology, 2008
- Physostigmine modulation of acetylcholine currents in COS cells transfected with mouse muscle nicotinic receptorNeuroscience Letters, 2006
- Physostigmine, galanthamine and codeine act as ‘noncompetitive nicotinic receptor agonists’ on clonal rat pheochromocytoma cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1995